Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Advancing Risk Stratification in Endometrial Cancer: Integrating Dynamic Circulating Tumor DNA and Proteomics-Based Liquid Biopsies for Enhanced Prognostic Precision

NCT07746024 is registered in ClinicalTrials.gov with Fondazione Policlinico Universitario Agostino Gemelli IRCCS as lead sponsor.

NCT NCT07746024
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07746024 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Advancing Risk Stratification in Endometrial Cancer: Integrating Dynamic Circulating Tumor DNA and Proteomics-Based Liquid Biopsies for Enhanced Prognostic Precision
Lead sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Phase
Observational
Overall status
Active, not recruiting
Start date
July 23, 2026
Completion date
August 1, 2029
Enrollment
400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endometrial cancer